Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.078 | 0.2 |